Immunome Inc (IMNM)
11.22
-0.05
(-0.44%)
USD |
NASDAQ |
Jan 06, 16:00
11.16
-0.06
(-0.53%)
After-Hours: 20:00
Immunome Shareholders Equity (Quarterly): 214.91M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Protalix BioTherapeutics Inc | 32.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.90M |
| Total Liabilities (Quarterly) | 41.99M |
| Current Ratio | 6.174 |